Nuvalent Inc (NUVL)
Healthcare
Biotechnology
124.00 $
+0.0%
vs. previous close
Closing price · As of: 21. Jul 2026
Nuvalent Inc (NUVL) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -92 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -22 | -23 | -30 | -36 | -41 | -46 | -62 | -55 | -77 | -70 | -73 | -92 | -313 | |
| – | – | 2.5 | – | – | – | – | – | – | – | – | – | – | |
| 5.8 | 6.9 | 7.5 | 14 | 15 | 15 | 16 | 20 | 22 | 22 | 22 | 29 | 95 | |
| 3.0 | – | – | – | – | – | – | – | – | – | – | – | – | |
| 4.0 | 6.4 | 2.7 | -2.1 | 4.3 | 9.4 | 0.2 | 12 | -2.5 | 12 | -2.5 | -13 | -5.9 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| 1.6 | 38 | -56 | -207 | 16 | -213 | -170 | 25 | 77 | 54 | -281 | -19 | -169 | |
| – | – | 0.4 | – | – | – | – | – | – | – | – | – | – | |
| 1.3 | 2.1 | 333 | 6.0 | 4.1 | 550 | 8.5 | 4.5 | 5.8 | 4.8 | 500 | 9.8 | 521 | |
| -19 | 18 | 247 | -237 | -21 | 292 | -224 | -25 | 6.6 | -12 | 146 | -102 | 39 | |
| -22 | -23 | -30 | -36 | -41 | -46 | -62 | -55 | -77 | -70 | -73 | -92 | -313 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: July 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.